Jayakumar Vadakekolathu
Cited by
Cited by
Genetic variations and interrelationships in Vanilla planifolia and few related species as expressed by RAPD polymorphism
D Minoo, VN Jayakumar, SS Veena, J Vimala, A Basha, KV Saji, KN Babu, ...
Genetic Resources and Crop Evolution 55 (3), 459-470, 2008
A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics
N Harner-Foreman, J Vadakekolathu, SA Laversin, MG Mathieu, ...
Scientific reports 7 (1), 1-18, 2017
Novel prostate acid phosphatase‐based peptide vaccination strategy induces antigen‐specific T‐cell responses and limits tumour growth in mice
JMS Saif, J Vadakekolathu, SS Rane, D McDonald, M Ahmad, M Mathieu, ...
European journal of immunology 44 (4), 994-1004, 2014
T-cell manipulation strategies to prevent graft-versus-host disease in haploidentical stem cell transplantation
J Vadakekolathu, S Rutella
Biomedicines 5 (2), 33, 2017
Phase 1 cohort expansion of flotetuzumab, a CD123× CD3 bispecific DART® protein in patients with relapsed/refractory acute myeloid leukemia (AML)
GL Uy, MP Rettig, N Vey, J Godwin, MC Foster, DA Rizzieri, ML Arellano, ...
Blood 132 (Supplement 1), 764-764, 2018
MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer
J Vadakekolathu, SIK Al-Juboori, C Johnson, A Schneider, ME Buczek, ...
Cell death & disease 9 (3), 1-12, 2018
Immune gene expression profiling in children and adults with acute myeloid leukemia identifies distinct phenotypic patterns
J Vadakekolathu, T Patel, S Reeder, H Schaarschmidt, M Schmitz, ...
Blood 130 (Supp 1), 3942A, 2017
Adaptive immune gene signatures correlate with response to Flotetuzumab, a CD123× CD3 bispecific DART® molecule, in patients with relapsed/refractory acute myeloid leukemia
S Rutella, SE Church, J Vadakekolathu, E Viboch, AH Sullivan, T Hood, ...
Blood 132 (suppl 1), 444, 2018
Genetic diversity and phylogenetic relationship among small cardamom (Elettaria cardamomum Maton.) cultivars and related genera using DNA markers
KN Babu, VN Jayakumar, M Divakaran, MN Venugopal, MR Sudarshan, ...
International Journal of Innovative Horticulture 1 (1), 47-56, 2012
Immune-phenotyping and transcriptomic profiling of peripheral blood mononuclear cells from patients with breast cancer: identification of a 3 gene signature which predicts …
GA Foulds, J Vadakekolathu, T Abdel-Fatah, D Nagarajan, S Reeder, ...
Frontiers in immunology 9, 2028, 2018
Capturing the complexity of the immune microenvironment of acute myeloid leukemia with 3D biology technology.
S Rutella, J Vadakekolathu, H Altmann, T Patel, S Reeder, Y Liang, ...
Journal of Clinical Oncology 36 (5_suppl), 50-50, 2018
Identification and characterisation of NANOG+/OCT-4high/SOX2+ doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines
RM Balahmar, DJ Boocock, C Coveney, S Ray, J Vadakekolathu, ...
Oncotarget 9 (6), 7054, 2018
A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study
S Wagner, J Vadakekolathu, SK Tasian, H Altmann, M Bornhäuser, ...
Blood advances 3 (8), 1330-1346, 2019
Discovery and application of immune biomarkers for hematological malignancies
D Zafeiris, J Vadakekolathu, S Wagner, AG Pockley, GR Ball, S Rutella
Expert review of molecular diagnostics 17 (11), 983-1000, 2017
Interferon-γ induces distinct mRNA and protein profiles in acute and chronic myeloid leukemia
J Vadakekolathu, R Meredith, PM Ross, S Wagner, S Reeder, ...
Blood 130 (Supp 1), 3945A, 2017
Immune infiltration correlates with TP53 mutational status in a multi-cohort acute myeloid leukemia study
S Rutella, J Vadakekolathu, S Reeder, J Ashforth, M Courtney, A Coutts, ...
Somatic embryogenesis and transgenic development in black pepper for delayed infection and decreased spread of foot rot caused by Phytophthora capsici
J Sinoj, TE Sheeja, RS Bhai, EJ Suraby, D Minoo, J Soji, VN Jayakumar, ...
Journal of Plantation Crops, 20-28, 2014
Immune Landscapes Predict Chemotherapy Resistance and Anti-Leukemic Activity of Flotetuzumab, an Investigational CD123× CD3 Bispecific Dart® Molecule, in Patients with Relapsed …
J Vadakekolathu, MD Minden, T Hood, SE Church, S Reeder, H Altmann, ...
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019
Flotetuzumab, an investigational CD123 x CD3 bispecific DART® protein, in salvage therapy for primary refractory and early relapsed acute myeloid leukemia (AML) patients
GL Uy, I Aldoss, MC Foster, DA Sallman, KL Sweet, DA Rizzieri, PH Sayre, ...
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019
Novel PAP-derived vaccine for the treatment of advanced prostate cancer
P Le Vu, J Vadakekolathu, H Nicholls, D Christensen, L Durrant, ...
European Journal of Cancer 92, S18, 2018
The system can't perform the operation now. Try again later.
Articles 1–20